NCT01497964 Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT01496313 To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer Status COMPLETED Phase PHASE4
NCT01493115 Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01487096 Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses Status COMPLETED Phase PHASE2
NCT01485900 Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment Status COMPLETED Phase PHASE1
NCT01485302 Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients Status COMPLETED Phase PHASE1
NCT01484600 Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01476475 Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients Status COMPLETED Phase PHASE2
NCT01472887 SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Status COMPLETED Phase PHASE2
NCT01471444 Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE3
NCT01470456 Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT01469338 Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel Status TERMINATED Phase PHASE2
NCT01463488 Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I Status COMPLETED Phase PHASE1
NCT01463397 Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain Status COMPLETED Phase PHASE2
NCT01462149 Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01461577 Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure Status COMPLETED Phase PHASE4
NCT01460459 Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes Status UNKNOWN Phase NA
NCT01459809 Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT01457911 Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin Status COMPLETED Phase PHASE3